Prepare for your visit
Eli Perez
Orange, CA · NPI 1619670403
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$1,367.06
in general payments reported to CMS, 2019-2025 · $495 in 2025
The $495 reported for 2025 was more than what 79% of providers received nationally.
Who reported paying
General payments only, top 6 by amount.
- Regeneron Healthcare Solutions, INC. $261.82
- Genentech USA, INC. $255.41
- Apellis Pharmaceuticals, INC. $245.78
- Abbvie INC. $239.24
- Bausch & Lomb Americas INC. $136.27
- Astellas Pharma US INC $114.31
Drugs and devices associated with these payments
Eylea Hd Vabysmo Syfovre Ozurdex Xipere Izervay Centurion Xen Glaucoma Treatment System Yutiq Clareon Stellaris
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Eli Perez listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/11688596/eli-perez